Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Helping families thrive in the face of uncertainty: Strengths based approaches to working with families affected by progressive neurological illness.
Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.
The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.
Astrocyte matricellular proteins that control excitatory synaptogenesis are regulated by inflammatory cytokines and correlate with paralysis severity during experimental autoimmune encephalomyelitis.
MyelStones: the executive roles of myelin basic protein in myelin assembly and destabilization in multiple sclerosis.
Effectiveness of muscle basal lamina carrying neural stem cells and olfactory ensheathing cells in spinal cord repair.
A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial.
Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis.
Update on Leukodystrophies: A Historical Perspective and Adapted Definition.
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.
Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis.
Paraoxonase 1 in neurological disorders.
The Challenges, Advantages, and Future of Phenome-Wide Association Studies.
P300 wave changes in patients with multiple sclerosis.
Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity.
Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating?
Does ability to walk reflect general functionality in inflammatory neuropathies?
Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic protein.
Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis.
Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis.
Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-beta.
Patient perspectives on switching disease-modifying therapies in the NARCOMS registry.
IL-11 in multiple sclerosis.
Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
Pages
« first
‹ previous
…
588
589
590
591
592
593
594
595
596
…
next ›
last »